KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Change in Account Payables (2016 - 2026)

Pacific Biosciences Of California has reported Change in Account Payables over the past 16 years, most recently at $1.7 million for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 52.55% year-over-year to $1.7 million; the TTM value through Dec 2025 reached $2.5 million, up 76.65%, while the annual FY2025 figure was $2.5 million, 76.65% up from the prior year.
  • Change in Account Payables for Q4 2025 was $1.7 million at Pacific Biosciences Of California, up from $1.3 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $6.6 million in Q1 2024 and troughed at -$5.6 million in Q3 2024.
  • A 5-year average of $667789.5 and a median of $180000.0 in 2022 define the central range for Change in Account Payables.
  • Biggest five-year swings in Change in Account Payables: soared 4065.36% in 2022 and later crashed 1520.0% in 2023.
  • Year by year, Change in Account Payables stood at $6.2 million in 2021, then crashed by 107.88% to -$486000.0 in 2022, then crashed by 208.64% to -$1.5 million in 2023, then soared by 341.8% to $3.6 million in 2024, then tumbled by 52.55% to $1.7 million in 2025.
  • Business Quant data shows Change in Account Payables for PACB at $1.7 million in Q4 2025, $1.3 million in Q3 2025, and $1.0 million in Q2 2025.